CD4 and neoplasm: Following recognition of a specific tumor-associated antigen presented by an appropriately activated APC, naïve CD4 T cells undergo several rounds of division and can become polarized into such distinct effector Th cell subsets that can differentially orchestrate antitumor immune responses, in part, through their production of signature cytokines.